{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:45:43Z","timestamp":1792086343707,"version":"4.4.0"},"reference-count":6,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj-2026-101148","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:30:13Z","timestamp":1792071013000},"page":"e101148","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["US-UK drug pricing deal: National Audit Office is to investigate costs"],"prefix":"10.1136","volume":"395","author":[{"given":"Tom","family":"Moberly","sequence":"first","affiliation":[{"name":"The BMJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"2026101510001031000_395.oct15_5.e101148.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r2538"},{"key":"2026101510001031000_395.oct15_5.e101148.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2026-340588","article-title":"Health costs of the UK-US trade deal on pharmaceuticals","volume":"394","author":"Cross","year":"2026","journal-title":"BMJ"},{"key":"2026101510001031000_395.oct15_5.e101148.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2026-100894"},{"key":"2026101510001031000_395.oct15_5.e101148.4","unstructured":"National Audit Office. Letter to Layla Moran MP. 30 Sep 2026. https:\/\/committees.parliament.uk\/publications\/55212\/standard\/pdf"},{"key":"2026101510001031000_395.oct15_5.e101148.5","unstructured":"Stein T. UK-US medicines deal: the public interest in publishing the evidence behind it. Nuffield Trust. 27 Aug 2026. https:\/\/www.nuffieldtrust.org.uk\/news-item\/uk-us-medicines-deal-the-public-interest-in-publishing-the-evidence-behind-it"},{"key":"2026101510001031000_395.oct15_5.e101148.6","doi-asserted-by":"crossref","unstructured":"Moberly T . UK drug agreement with Trump faces legal challenge over changes to NICE. BMJ2026;393:e191827. doi:10.1136\/bmj-2026-191827.","DOI":"10.1136\/bmj-2026-191827"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2026-101148","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2026-101148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:00:17Z","timestamp":1792083617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2026-101148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":6,"alternative-id":["10.1136\/bmj-2026-101148"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2026-101148","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}